Zhijie Yu

974 total citations
35 papers, 707 citations indexed

About

Zhijie Yu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Zhijie Yu has authored 35 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Hepatology. Recurrent topics in Zhijie Yu's work include Ferroptosis and cancer prognosis (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer-related molecular mechanisms research (4 papers). Zhijie Yu is often cited by papers focused on Ferroptosis and cancer prognosis (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer-related molecular mechanisms research (4 papers). Zhijie Yu collaborates with scholars based in China, United Kingdom and United States. Zhijie Yu's co-authors include Oscar H. Franco, An Pan, Huaixing Li, Ling Lu, Xu Lin, Tony Dadd, Lin Xu, Erkki Vartiainen, Zeyu Guo and Huiguang Tian and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Oncogene.

In The Last Decade

Zhijie Yu

33 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhijie Yu China 14 174 166 131 91 74 35 707
Christine L. Baker United States 19 162 0.9× 347 2.1× 185 1.4× 71 0.8× 74 1.0× 58 1.5k
Daniel B. Rosoff United States 16 83 0.5× 203 1.2× 133 1.0× 28 0.3× 153 2.1× 32 805
Ronny Baber Germany 16 140 0.8× 144 0.9× 52 0.4× 20 0.2× 95 1.3× 56 811
Jieyun Yin China 22 230 1.3× 251 1.5× 205 1.6× 63 0.7× 128 1.7× 74 1.4k
Pavan S. Reddy United States 13 90 0.5× 78 0.5× 128 1.0× 77 0.8× 40 0.5× 34 1.2k
Lu Sun China 15 149 0.9× 74 0.4× 39 0.3× 22 0.2× 135 1.8× 67 747
Margery Gass United States 8 180 1.0× 72 0.4× 305 2.3× 33 0.4× 32 0.4× 13 1.1k
Irina Bondarenko United States 12 183 1.1× 163 1.0× 202 1.5× 22 0.2× 35 0.5× 24 1.1k
Yasin Tayem Bahrain 12 95 0.5× 169 1.0× 65 0.5× 38 0.4× 18 0.2× 37 566
Arno W. F. T. Toorians Netherlands 14 153 0.9× 159 1.0× 35 0.3× 33 0.4× 83 1.1× 17 1.0k

Countries citing papers authored by Zhijie Yu

Since Specialization
Citations

This map shows the geographic impact of Zhijie Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhijie Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhijie Yu more than expected).

Fields of papers citing papers by Zhijie Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhijie Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhijie Yu. The network helps show where Zhijie Yu may publish in the future.

Co-authorship network of co-authors of Zhijie Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhijie Yu. A scholar is included among the top collaborators of Zhijie Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhijie Yu. Zhijie Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Zhijie, et al.. (2025). Nucleus-targeted ruthenium(II) complex triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy by activating cGAS–STING pathway. Journal of Inorganic Biochemistry. 267. 112871–112871. 4 indexed citations
2.
Lu, Dongrui R., Zhao Zhang, Xiangwu Zheng, et al.. (2025). MRI Radiomics to Predict Early Treatment Response to TACE Combined with Lenvatinib Plus a PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Hepatocellular Carcinoma. Volume 12. 985–998. 1 indexed citations
3.
Lin, Jiawei, Yifan Kong, Dongrui R. Lu, et al.. (2025). Explainable machine learning model for predicting the transarterial chemoembolization response and subtypes of hepatocellular carcinoma patients. BMC Gastroenterology. 25(1). 503–503.
4.
5.
Pan, Yating, Jinrong Zhu, Dongrui R. Lu, et al.. (2024). PH-sensitive adriamycin hydrochloride and oxaliplatin dual-loaded microspheres synergistically enhance local injections effect of hepatocellular carcinoma. Materials Today Bio. 29. 101311–101311. 2 indexed citations
6.
Zhu, Yiyi, Zhijie Yu, Xipeng Chen, et al.. (2024). SKI-606, a Src inhibitor, ameliorates benzene-induced hematotoxicity via blocking ROS/Src kinase-mediated p38 and Akt signaling pathways. Ecotoxicology and Environmental Safety. 286. 117223–117223.
7.
8.
Du, Xiaojing, et al.. (2023). HELLS modulates the stemness of intrahepatic cholangiocarcinoma through promoting senescence-associated secretory phenotype. Computational and Structural Biotechnology Journal. 21. 5174–5185. 5 indexed citations
9.
Xie, Shicheng, et al.. (2023). Novel risk model based on angiogenesis-related lncRNAs for prognosis prediction of hepatocellular carcinoma. Cancer Cell International. 23(1). 159–159. 4 indexed citations
10.
Du, Xiaojing, et al.. (2022). Loss of GABARAPL1 confers ferroptosis resistance to cancer stem‐like cells in hepatocellular carcinoma. Molecular Oncology. 16(20). 3703–3719. 22 indexed citations
11.
12.
Zhu, Kai, Zhijie Yu, Lili Chen, et al.. (2022). A novel 10-gene ferroptosis-related prognostic signature in acute myeloid leukemia. Frontiers in Oncology. 12. 1023040–1023040. 11 indexed citations
13.
Feng, Qi, Wenxing Qin, Yao Zhang, et al.. (2021). Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 17 indexed citations
14.
Zhou, Bin, et al.. (2021). Bortezomib suppresses self‐renewal and leukemogenesis of leukemia stem cell by NF‐ĸB‐dependent inhibition of CDK6 in MLL‐rearranged myeloid leukemia. Journal of Cellular and Molecular Medicine. 25(6). 3124–3135. 8 indexed citations
15.
Ye, Xinchun, Risheng Huang, Zhijie Yu, et al.. (2021). Clinical Characteristics of Patients With Re-admitted of Novel Coronavirus 2019 (nCOVID-19) in Wenzhou, China. Frontiers in Public Health. 9. 649178–649178. 2 indexed citations
16.
Li, Yuping, Keqing Shi, Qi Feng, et al.. (2020). Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study. International Journal of Infectious Diseases. 103. 507–513. 16 indexed citations
17.
Han, Yixiang, Yifen Shi, Wanling Xu, et al.. (2018). Benzene induces haematotoxicity by promoting deacetylation and autophagy. Journal of Cellular and Molecular Medicine. 23(2). 1022–1033. 26 indexed citations
18.
Bi, Laixi, Zhijie Yu, Jianbo Wu, et al.. (2015). Honokiol Inhibits Constitutive and Inducible STAT3 Signaling via PU.1-Induced SHP1 Expression in Acute Myeloid Leukemia Cells. The Tohoku Journal of Experimental Medicine. 237(3). 163–172. 25 indexed citations
19.
20.
Pan, An, Ling Lu, Oscar H. Franco, et al.. (2009). Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese. Journal of Affective Disorders. 118(1-3). 240–243. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine L. Baker Breakdown of academic impact, for papers by Daniel B. Rosoff Breakdown of academic impact, for papers by Ronny Baber Breakdown of academic impact, for papers by Jieyun Yin Breakdown of academic impact, for papers by Pavan S. Reddy Breakdown of academic impact, for papers by Lu Sun Breakdown of academic impact, for papers by Margery Gass Breakdown of academic impact, for papers by Irina Bondarenko Breakdown of academic impact, for papers by Yasin Tayem Breakdown of academic impact, for papers by Arno W. F. T. Toorians
Rankless by CCL
2026